MX2016011500A - Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment. - Google Patents

Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment.

Info

Publication number
MX2016011500A
MX2016011500A MX2016011500A MX2016011500A MX2016011500A MX 2016011500 A MX2016011500 A MX 2016011500A MX 2016011500 A MX2016011500 A MX 2016011500A MX 2016011500 A MX2016011500 A MX 2016011500A MX 2016011500 A MX2016011500 A MX 2016011500A
Authority
MX
Mexico
Prior art keywords
extract
alvaradoa
amorphoides
found
cancer treatment
Prior art date
Application number
MX2016011500A
Other languages
Spanish (es)
Inventor
Esther Moo Puc Rosa
Rubén PERAZA SÁNCHEZ Sergio
Javier QUINTAL NOVELO Carlos
Original Assignee
Inst Mexicano Del Seguro Social
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Mexicano Del Seguro Social filed Critical Inst Mexicano Del Seguro Social
Priority to MX2016011500A priority Critical patent/MX2016011500A/en
Publication of MX2016011500A publication Critical patent/MX2016011500A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present disclosure is related to an Alvaradoa amorphoides methanolic extract, a plant that is found in the Yucatan peninsula that has anti-carcinogenic properties. Also, the present invention is related to the different metabolites found in this plant. The extract was standardized by the content of several active compounds found in different fractions of the same. The active compounds or metabolites were isolated, purified and identified. The present invention demonstrates that the extract is useful in the preparation of a pharmaceutical composition for the cancer treatment in several modalities. The Methanolic extract has antiproliferative and cytotoxic activity being demonstrated in several tumor cell lines. These results allow establishing a new phytopharmaceutical with anticarcinogenic properties.
MX2016011500A 2016-09-06 2016-09-06 Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment. MX2016011500A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016011500A MX2016011500A (en) 2016-09-06 2016-09-06 Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016011500A MX2016011500A (en) 2016-09-06 2016-09-06 Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment.

Publications (1)

Publication Number Publication Date
MX2016011500A true MX2016011500A (en) 2018-03-05

Family

ID=62778616

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011500A MX2016011500A (en) 2016-09-06 2016-09-06 Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment.

Country Status (1)

Country Link
MX (1) MX2016011500A (en)

Similar Documents

Publication Publication Date Title
PH12017500803A1 (en) Anti-pd-1 antibodies
MX2019012233A (en) Anti-sirp alpha antibodies.
JOP20200055A1 (en) Pyrazolopyrimidinone compounds and uses thereof
MX2021006531A (en) Rna containing composition for treatment of tumor diseases.
TW201613901A (en) New compounds
NZ752526A (en) Pyrrolobenzodiazepine conjugates
MY201925A (en) Macrocyclic compounds and uses thereof
CL2016002308A1 (en) Nanoparticles comprising a hydrophobic acid, a diblock copolymer pla-peg or plga-peg, and 1-4-4-dimethylamino piperidin-1-yl carbonylphenyl-3-4-4,6-dimorfolin-4-yl-1, 3,5-triazin-2-ylphenylurea pharmaceutical composition preparation and use process to treat cancer
PH12018500174A1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
PH12018502634A1 (en) Topical compositions of apremilast
MX2019001286A (en) Cannabis composition.
JOP20200152A1 (en) Macrocyclic compounds for treating disease
PH12016501790B1 (en) Pharmaceutical compositions of therapeutically active compounds
EA201691844A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
TR201901077T4 (en) Combined Preparations for Cancer or Infection Treatment
MY193175A (en) Apremilast pharmaceutical compositions
ECSP16084317A (en) PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE
PH12020550964A1 (en) Heavy chain antibodies binding to cd22
IN2014MU00303A (en)
PH12017500853A1 (en) Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases
NZ720963A (en) Improved method for producing ginkgo extracts
JO3565B1 (en) Angiopoietin-like 4 antibodies and methods of use
CR20220656A (en) Multi-specific antibodies binding to bcma
CR20230525A (en) Anti-cd20 antibodies and car-t structures
PH12017501122A1 (en) Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof